IBDEI0L2 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10324,1,5,0)
 ;;=5^Oral Aphthae
 ;;^UTILITY(U,$J,358.3,10324,2)
 ;;=^114480
 ;;^UTILITY(U,$J,358.3,10325,0)
 ;;=692.72^^67^674^44
 ;;^UTILITY(U,$J,358.3,10325,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10325,1,4,0)
 ;;=4^692.72
 ;;^UTILITY(U,$J,358.3,10325,1,5,0)
 ;;=5^Photosensitivity
 ;;^UTILITY(U,$J,358.3,10325,2)
 ;;=^93951
 ;;^UTILITY(U,$J,358.3,10326,0)
 ;;=692.6^^67^674^46
 ;;^UTILITY(U,$J,358.3,10326,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10326,1,4,0)
 ;;=4^692.6
 ;;^UTILITY(U,$J,358.3,10326,1,5,0)
 ;;=5^Poison Ivy
 ;;^UTILITY(U,$J,358.3,10326,2)
 ;;=^271908
 ;;^UTILITY(U,$J,358.3,10327,0)
 ;;=698.0^^67^674^54
 ;;^UTILITY(U,$J,358.3,10327,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10327,1,4,0)
 ;;=4^698.0
 ;;^UTILITY(U,$J,358.3,10327,1,5,0)
 ;;=5^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,10327,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,10328,0)
 ;;=698.9^^67^674^53
 ;;^UTILITY(U,$J,358.3,10328,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10328,1,4,0)
 ;;=4^698.9
 ;;^UTILITY(U,$J,358.3,10328,1,5,0)
 ;;=5^Pruritic Disorder,Unsp
 ;;^UTILITY(U,$J,358.3,10328,2)
 ;;=^123977
 ;;^UTILITY(U,$J,358.3,10329,0)
 ;;=696.1^^67^674^55
 ;;^UTILITY(U,$J,358.3,10329,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10329,1,4,0)
 ;;=4^696.1
 ;;^UTILITY(U,$J,358.3,10329,1,5,0)
 ;;=5^Psoriasis
 ;;^UTILITY(U,$J,358.3,10329,2)
 ;;=^87816
 ;;^UTILITY(U,$J,358.3,10330,0)
 ;;=287.0^^67^674^56
 ;;^UTILITY(U,$J,358.3,10330,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10330,1,4,0)
 ;;=4^287.0
 ;;^UTILITY(U,$J,358.3,10330,1,5,0)
 ;;=5^Purpura, Vascular
 ;;^UTILITY(U,$J,358.3,10330,2)
 ;;=^101365
 ;;^UTILITY(U,$J,358.3,10331,0)
 ;;=782.1^^67^674^57
 ;;^UTILITY(U,$J,358.3,10331,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10331,1,4,0)
 ;;=4^782.1
 ;;^UTILITY(U,$J,358.3,10331,1,5,0)
 ;;=5^Rash NOS
 ;;^UTILITY(U,$J,358.3,10331,2)
 ;;=^102948
 ;;^UTILITY(U,$J,358.3,10332,0)
 ;;=706.2^^67^674^61
 ;;^UTILITY(U,$J,358.3,10332,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10332,1,4,0)
 ;;=4^706.2
 ;;^UTILITY(U,$J,358.3,10332,1,5,0)
 ;;=5^Sebaceous Cyst
 ;;^UTILITY(U,$J,358.3,10332,2)
 ;;=^41304
 ;;^UTILITY(U,$J,358.3,10333,0)
 ;;=690.10^^67^674^64
 ;;^UTILITY(U,$J,358.3,10333,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10333,1,4,0)
 ;;=4^690.10
 ;;^UTILITY(U,$J,358.3,10333,1,5,0)
 ;;=5^Seborrheic Dermatitis
 ;;^UTILITY(U,$J,358.3,10333,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,10334,0)
 ;;=702.11^^67^674^62
 ;;^UTILITY(U,$J,358.3,10334,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10334,1,4,0)
 ;;=4^702.11
 ;;^UTILITY(U,$J,358.3,10334,1,5,0)
 ;;=5^Seborrh Keratosis, Inflammatory
 ;;^UTILITY(U,$J,358.3,10334,2)
 ;;=^303311
 ;;^UTILITY(U,$J,358.3,10335,0)
 ;;=702.19^^67^674^63
 ;;^UTILITY(U,$J,358.3,10335,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10335,1,4,0)
 ;;=4^702.19
 ;;^UTILITY(U,$J,358.3,10335,1,5,0)
 ;;=5^Seborrh Keratosis, Other
 ;;^UTILITY(U,$J,358.3,10335,2)
 ;;=^303312
 ;;^UTILITY(U,$J,358.3,10336,0)
 ;;=686.9^^67^674^65
 ;;^UTILITY(U,$J,358.3,10336,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10336,1,4,0)
 ;;=4^686.9
 ;;^UTILITY(U,$J,358.3,10336,1,5,0)
 ;;=5^Skin Infec, Local Unsp
 ;;^UTILITY(U,$J,358.3,10336,2)
 ;;=^123943
 ;;^UTILITY(U,$J,358.3,10337,0)
 ;;=708.9^^67^674^78
 ;;^UTILITY(U,$J,358.3,10337,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10337,1,4,0)
 ;;=4^708.9
 ;;^UTILITY(U,$J,358.3,10337,1,5,0)
 ;;=5^Urticaria, Unsp
 ;;^UTILITY(U,$J,358.3,10337,2)
 ;;=^124650
 ;;^UTILITY(U,$J,358.3,10338,0)
 ;;=078.10^^67^674^79
 ;;^UTILITY(U,$J,358.3,10338,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10338,1,4,0)
 ;;=4^078.10
